SCHEMBL7760875

SCHEMBL7760875

Cc1c(C)c(C)c(CNc2ccccc2C(=O)NCCN)c(C)c1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 4/20 0.46
ADRA1A P35348 4/20 0.46
ADRA1B P35368 4/20 0.46
HDAC3 O15379 2/20 0.44
HPGD P15428 6/20 0.42
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 3/20 0.42
HSD17B10 Q99714 2/20 0.42
HDAC1 Q13547 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
TSHR P16473 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
TP53 P04637 1/20 0.40
MAOB P27338 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
MT-CO2 P00403 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29922998 0.78 CRBN (0.54) ADRA1DADRA1AADRA1BHDAC3HPGD
SCHEMBL5055189 0.78 CRBN (0.54) ADRA1DADRA1AADRA1BHDAC3HPGD
SCHEMBL7760016 0.77 HPGD (0.53) HDAC3HPGDALDH1A1KDM4EHDAC1
SCHEMBL11230535 0.76 HPGD (0.64) HDAC3HPGDALDH1A1KDM4ETSHR
SCHEMBL3861140 0.75 TSHR (0.60) HPGDTSHRHTTSMN1; SMN2MEN1
SCHEMBL7761935 0.75 KMT2A (0.51) HDAC3HPGDALDH1A1KDM4EHSD17B10
SCHEMBL7756867 0.75 HCRTR1 (0.56) ALDH1A1TSHRMEN1KMT2ANPC1
SCHEMBL8652703 0.73 TSHR (0.53) HPGDALDH1A1KDM4EHSD17B10TSHR
SCHEMBL19347407 0.72 TSHR (0.49) HPGDALDH1A1KDM4ETSHRHTT
SCHEMBL21883932 0.71 TSHR (0.56) HDAC3HPGDALDH1A1KDM4EHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6541479-B1 Derivatives of thiosalicylic acid and o-aminobenzoic acid MASSACHUSETTS COLLEGE OF PHARMACY 2003-04-01 US disclosed